Latest Insider Transactions at Co Diagnostics, Inc. (CODX)
This section provides a real-time view of insider transactions for Co Diagnostics, Inc. (CODX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Co-Diagnostics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Co-Diagnostics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 24
2020
|
Dwight H Egan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,236
-10.47%
|
$5,236
$1.1 P/Share
|
|
Nov 24
2020
|
Dwight H Egan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$50,000
$1.1 P/Share
|
|
Nov 23
2020
|
Dwight H Egan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
71,569
-100.0%
|
$715,690
$10.44 P/Share
|
|
Nov 23
2020
|
Dwight H Egan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,431
-10.54%
|
$8,431
$1.1 P/Share
|
|
Nov 23
2020
|
Dwight H Egan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
80,000
+50.0%
|
$80,000
$1.1 P/Share
|
|
Nov 23
2020
|
Richard S Serbin |
BUY
Exercise of conversion of derivative security
|
Direct |
17,000
+50.0%
|
-
|
|
Nov 23
2020
|
Eugene Durenard |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
-
|
|
Nov 20
2020
|
Dwight H Egan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,017
-100.0%
|
$198,187
$11.09 P/Share
|
|
Nov 20
2020
|
Dwight H Egan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,983
-9.92%
|
$1,983
$1.1 P/Share
|
|
Nov 20
2020
|
Dwight H Egan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$20,000
$1.1 P/Share
|
|
Apr 01
2020
|
Reagents, LLC |
SELL
Other acquisition or disposition
|
Direct |
25,000
-1.41%
|
$4,812,625,000
$192505.0 P/Share
|
|
Sep 19
2017
|
Reagents, LLC |
SELL
Other acquisition or disposition
|
Direct |
181,817
-9.31%
|
-
|